The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Acetylcholinesterase inhibitors from plants
Abstract
Inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown of acetylcholine, is considered as a promising strategy for the treatment of neurological disorders such as Alzheimer's disease, senile dementia, ataxia and myasthenia gravis. A potential source of AChE inhibitors is certainly provided by the abundance of plants in nature. This article aims to provide a comprehensive literature survey of plants that have been tested for AChE inhibitory activity. Numerous phytoconstituents and promising plant species as AChE inhibitors are being reported in this communication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The secondary metabolites of the various classes such as alkaloids, terpenoids, coumarins, flavonoids, etc. have been reported to have potent AChEinhibitory activity [71,72,73,74].”
From Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy (2021) · cites this paper as [73]
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,221
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C. V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08267-3 · Cited by 752
Principles of Medicinal Chemistry
Delgado, J. N. (1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600641047 · Cited by 723
Principles of medicinal chemistry
Foye, W. O. (1974) · Cited by 476
Rhee, I. K., van de Meent, M. H. M., Ingkaninan, K., & Verpoorte, R. (2001) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)00624-0 · Cited by 465
Perry, N. S. L., Houghton, P. J., Theobald, A. E., Jenner, P. G., & Perry, E. K. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774598 · Cited by 458
Self-citationHowes, M. R., & Houghton, P. J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00128-x · Cited by 443
Self-citationPresynaptic Cholinergic Dysfunction in Patients with Dementia
Sims, N. R., Bowen, D. M., Allen, S. J., Smith, C., Neary, D., Thomas, D. J., & DAVISON, A. N. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb11311.x · Cited by 421
Howes, M. R., Perry, N. S. L., & Houghton, P. J. (2003) · Phytotherapy Research · doi:10.1002/ptr.1280 · Cited by 418
Self-citation"Compendium of pharmaceuticals and specialties".
Krogh, C. (1983) · PubMed · Cited by 410
The cholinergic system in Alzheimer's disease
Kása, P., Rakonczay, Z., & Gulya, K. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00028-2 · Cited by 410
Scott, L. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200060050-00008 · Cited by 383
Structure of acetylcholinesterase complexed with the nootropic alkaloid, (–)-huperzine A
Raves, M. L., Harel, M., Pang, Y., Silman, I., Kozikowski, A. P., & Sussman, J. L. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0197-57 · Cited by 374
Ingkaninan, K., Temkitthawon, P., Chuenchom, K., Yuyaem, T., & Thongnoi, W. (2003) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2003.08.008 · Cited by 367
Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts
López, S., Bastida, J., Viladomat, F., & Codina, C. J. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02034-9 · Cited by 359
New Perspectives on Alzheimer's Disease
Price, D. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002421 · Cited by 354
Marston, A., Kissling, J., & Hostettmann, K. (2002) · Phytochemical Analysis · doi:10.1002/pca.623 · Cited by 345
Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants
Orhan, İ. E., Şener, B., Choudhary, M. I., & Khalid, A. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2003.11.016 · Cited by 302
Enz, A., Amstutz, R., Boddeke, H. W. G. M., Gmelin, G., & Malanowski, J. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62429-2 · Cited by 301
A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba
Das, A., Shanker, G., Nath, C., Pal, R., Singh, S., & Singh, H. K. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00940-1 · Cited by 264
Perry, E. K., Haroutunian, V. H., Davis, K. L., Levy, R., Lantos, P. L., Eagger, S. A., Honavar, M., Dean, A. F., Griffiths, M., McKeith, I. G., et al. (1994) · Neuroreport · doi:10.1097/00001756-199403000-00002 · Cited by 252
DeKosky, S. T., Harbaugh, R. E., Schmitt, F. A., Bakay, R. A. E., Chui, H. C., Knopman, D. S., Reeder, T. M., Shetter, A. G., Senter, H. J., Markesbery, W. R., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320505 · Cited by 222
Ingkaninan, K., de Best, C. M., van der Heijden, R., Hofte, A. J. P., Karabatak, B., Irth, H., Tjaden, U. R., van der Greef, J., & Verpoorte, R. (2000) · Journal of Chromatography A · doi:10.1016/s0021-9673(99)01292-3 · Cited by 219
Oh, M., Houghton, P. J., Whang, W. K., & Cho, J. (2004) · Phytomedicine · doi:10.1016/j.phymed.2004.03.001 · Cited by 194
Self-citationSchulz, V. (2003) · Phytomedicine · doi:10.1078/1433-187x-00302 · Cited by 164
In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease
Perry, N. S. L., Houghton, P. J., Sampson, J., Theobald, A. E., Hart, S., Lis‐Balchin, M., Hoult, J. R. S., Evans, P., Jenner, P. G., Milligan, S. R., et al. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011777846 · Cited by 161
Self-citationBioactive natural products as a potential source of new pharmacophores. A theory of memory
Rahman, A., & Choudhary, M. I. (2001) · Pure and Applied Chemistry · doi:10.1351/pac200173030555 · Cited by 155
The acetylcholinesterase-inhibitory activity of steroidal glycoalkaloids and their aglycones
Roddick, J. G. (1989) · Phytochemistry · doi:10.1016/s0031-9422(00)98055-5 · Cited by 138
Evaluation of Indian Traditional Medicine
Mukherjee, P. K. (2001) · Drug Information Journal · doi:10.1177/009286150103500235 · Cited by 138
Self-citationCholinergic therapy for Down's syndrome
Kishnani, P. S., Sullivan, J. A., Walter, B. K., Spiridigliozzi, G. A., Doraiswamy, P. M., & Krishnan, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05285-4 · Cited by 122
Inhibitory Effect of Ursolic Acid Purified from Origanum majorana L. on the Acetylcholinesterase
Chung, Y.-K., Heo, H. J., Kim, E.-K., Kim, H.-K., Huh, T., Lim, Y., Kim, S.-K., & Shin, D.-H. (2001) · Molecules and Cells · doi:10.1016/s1016-8478(23)17016-6 · Cited by 121
Andrade, M. T., Lima, J. A., Pinto, A. C., Rezende, C. M., Carvalho, M. P., & Epifanio, R. D. A. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.03.045 · Cited by 117
Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P., & Perry, N. S. L. (1998) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.1998.4.419 · Cited by 113
Self-citationDrug treatments for Alzheimer's disease
KELLY, C. A., Harvey, R. J., & Cayton, H. (1997) · BMJ · doi:10.1136/bmj.314.7082.693 · Cited by 111
Personal paper: New drug treatment for Alzheimer's disease: lessons for healthcare policy
Melzer, D. R. (1998) · BMJ · doi:10.1136/bmj.316.7133.762 · Cited by 108
Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’ disease
Giacobini, E. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_17 · Cited by 91
Gottwald, M. D., & Rozanski, R. I. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.10.1673 · Cited by 91
Wang, T., & Tang, X. C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00199-x · Cited by 82
Cholinergic therapies in Alzheimer's disease
Siddiqui, M. F., & Levey, A. I. (1999) · Drugs of the Future · doi:10.1358/dof.1999.024.04.668318 · Cited by 78
Screening of Non‐Alkaloidal Natural Compounds as Acetylcholinesterase Inhibitors
Brühlmann, C., Marston, A., Hostettmann, K., Carrupt, P., & Testa, B. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490064 · Cited by 77
Acetylcholinesterase inhibitors from the aerial parts ofCorydalis speciosa
Kim, D. K., Lee, K. T., Baek, N., Kim, S., Park, H. W., Lim, J., Shin, T. Y., Eom, D. O., Yang, J. H., & Eun, J. S. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02975117 · Cited by 75
Xanthones fromGentiana campestrisas New Acetylcholinesterase Inhibitors
Urbain, A., Marston, A., Queiroz, E. F., Ndjoko, K., & Hostettmann, K. (2004) · Planta Medica · doi:10.1055/s-2004-832632 · Cited by 74
(+)-.ALPHA.-Viniferin, a Stilbene Trimer from Caragana chamlague, Inhibits Acetylcholinesterase.
Sung, S. H., Kang, S. Y., Lee, K. Y., Park, M. J., Kim, J. H., Park, J. H., Kim, Y. C., Kim, J., & Kim, Y. C. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.125 · Cited by 71
Cholinergic therapy in dementia
Whitehouse, P. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04254.x · Cited by 62
Andrisano, V., Bartolini, M., Gotti, R., Cavrini, V., & Félix, G. (2001) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00571-5 · Cited by 61
Invited Review Anticholinesterases: dramatic aspects of their use and misuse
Karczmar, A. G. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00123-x · Cited by 61
Siqueira, I. R., Fochesatto, C., da Silva, A. L., Nunes, D. S., Battastini, A. M. O., Netto, C. A., & Elisabetsky, E. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00113-8 · Cited by 60
Tang, X.-C., Kindel, G. H., Kozikowski, A. P., & Hanin, I. (1994) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(94)01182-6 · Cited by 60
Cholinesterase inhibitory and spasmolytic potential of steroidal alkaloids
Khalid, A., Ul‐Haq, Z., Ghayur, M. N., Feroz, F., Rahman, A., Gilani, A. H., & Choudhary, M. I. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.08.003 · Cited by 59
Acetylcholinesterase inhibitors from the roots ofangelica dahurica
Kim, D. K., Lim, J., Yang, J. H., Eom, D. O., Eun, J. S., & Leem, K. H. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02977004 · Cited by 58
Kim, D. K. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976997 · Cited by 50
New Acetylcholinesterase‐Inhibitory Pregnane Glycosides of Cynanchum atratum Roots
Lee, K. Y., Sung, S. H., & Kim, Y. C. (2003) · Helvetica Chimica Acta · doi:10.1002/hlca.200390047 · Cited by 49
Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
Ashani, Y., Grunwald, J., Kronman, C., Velan, B., & Avigdor Shafferman, C. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10030-8 · Cited by 48
Acetylcholine Esterase Inhibitors inRhodiola rosea
Hillhouse, B. J., Ming, D. S., French, C. J., & Towers, G. H. N. (2004) · Pharmaceutical Biology · doi:10.1080/13880200490505636 · Cited by 37
Rizzi, A. M., Schuh, R., Brückner, A., Cvitkovich, B., Kremser, L., Jordis, U., Fröhlich, J., Küenburg, B., & Czollner, L. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00186-3 · Cited by 30
Ahmad, W., Ahmad, B., Ahmad, M., Iqbal, Z. M., Nisar, M. F., & Ahmad, M. S. (2003) · Journal of Biological Sciences · doi:10.3923/jbs.2003.1046.1049 · Cited by 25
Blockade on sodium, potassium, and calcium channels by a new antiarrhythmic agent CPU 86017
Dai, D., Yu, F., Li, H., Tang, Y., An, L., Huang, W., Peng, S., Hao, X., Zhou, B., & Hu, C. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199610)39:2 · Cited by 24
Burns, A. S., Blessed, G., & Byrne, E. J. (1996) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199612)11:12 · Cited by 9
Cited by
Sorted by citations
Kennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684
Natural products and drug discovery
Ji, H., Li, X., & Zhang, H. (2009) · EMBO Reports · doi:10.1038/embor.2009.12 · Cited by 648
The Ayurvedic medicine Clitoria ternatea—From traditional use to scientific assessment
Mukherjee, P. K., Kumar, V., Kumar, N. S., & Heinrich, M. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.09.009 · Cited by 369
Self-citationNatural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy
Murray, A. P., Faraoni, M. B., Castro, M., Alza, N. P., & Cavallaro, V. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040004 · Cited by 352
Plants traditionally used in age related brain disorders—A survey of ethnobotanical literature
Adams, M. A., Gmünder, F., & Hamburger, M. O. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.07.016 · Cited by 328
Metadata
- Authors
- Mukherjee, P. K., Kumar, V., Mal, M., & Houghton, P. J.
- Affiliations
- Jadavpur University (IN)
- King's College London (GB)
- Corresponding author
- Mukherjee, Pulok K.
- Venue
- Phytomedicine
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 14
- Issue
- 4
- Pages
- 289-300
- ISSN
- 0944-7113 (ISSN-L)
- OpenAlex
- W2060288971
- Cited by
- 809
- References
- 62
- Citations by year
- 2026: 19 · 2025: 38 · 2024: 45 · 2023: 55 · 2022: 56 · 2021: 50 · 2020: 59 · 2019: 44 · 2018: 51 · 2017: 54 · 2016: 61 · 2015: 56 · 2014: 50 · 2013: 35 · 2012: 41
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Phytomedicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Keywords
- acetylcholinesterase inhibitors, phytochemicals, phytochemical constituents, Alzheimer's disease, senile dementia, myasthenia gravis, ataxia, acetylcholine, plant species screening
- MeSH terms
- Alzheimer Disease, Cholinesterase Inhibitors, Humans, Phytotherapy, Plant Extracts, Plants, Medicinal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review